Palisade Bio (PALI) Total Debt Growth (1y) (2014 - 2025)
Palisade Bio (PALI) Total Debt Growth (1y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 103.99% |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 3.84% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.07% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Palisade Bio | 985.76 | -132.63 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -55.70% |
| Mar 31, 2025 | -51.75% |
| Dec 31, 2021 | -92.38% |
| Mar 31, 2017 | -27.64% |
| Dec 31, 2016 | -5.75% |
| Sep 30, 2016 | -5.37% |
| Jun 30, 2016 | 7.67% |
| Mar 31, 2016 | -21.07% |
| Dec 31, 2015 | -9.77% |
| Sep 30, 2015 | 60.20% |
| Jun 30, 2015 | 41.05% |
| Mar 31, 2015 | 26.15% |
| Dec 31, 2014 | 14.15% |
| Sep 30, 2014 | -25.86% |
| Jun 30, 2014 | -16.20% |
| Mar 31, 2014 | -6.76% |